Supportive Cancer Care

Cancer Care, Anywhere.

Advancing the care and supportive treatment of cancer.

Wherever you are in your cancer journey, we're here to help! Supportive cancer care therapies include all therapies that fall outside of the standard of care, which are implemented to help reduce adverse events, and/or support the standards of care while promoting survivorship and quality of life in the patient.

Become a Patient Explore the Therapies
Dr. Steve Rallis with a patient

Our approach

Working alongside your oncology team — never instead of it.

While integrative cancer therapies such as high dose Vitamin C or mistletoe therapy should never be considered as alternatives to chemotherapy, radiation, or surgery, these therapies are playing an increasingly expanded role in whole-patient cancer care.

Every plan is built in collaboration with your existing healthcare team, with the goal of reducing the side effects of conventional treatment, supporting your resilience through it, and protecting your quality of life at every stage.

"We are absolutely committed to becoming our community's preferred choice for the supportive treatment of cancer." Dr. Steve Rallis, DC, ND

What we offer

Supportive therapies, tailored to the whole patient.

Each plan draws on the tools below in the combination that fits your diagnosis, your standard-of-care treatment, and your goals.

Nutrition & Lifestyle Counselling

Nutrition and lifestyle counselling are central components of any naturopathic care plan — this is especially true in supportive cancer care!

Nutritional & Botanical Supplementation

Targeting the right supplements at the right time is a key component in the metabolic approach to supportive cancer care.

IV Therapies

High-dose intravenous vitamin C (HDIVC) therapy is a cornerstone therapy in integrative oncology.

Laboratory Diagnostics

From specific cancer markers to inflammatory markers to metabolic markers, frequent laboratory assessments (blood work) help us critically evaluate progress and efficacy.

Mistletoe Therapy

One of the most widely used alternative cancer therapies, mistletoe is a direct immune stimulator that seems to improve quality of life (QOL).

Supportive Medications

Supportive medications such as low dose naltrexone (LDN) are gaining momentum in integrative oncology.

Cancer care, anywhere

Care that reaches you, wherever you are.

Naturopathic doctors are eligible to provide supportive cancer care to any patient who resides in Ontario, or any province or territory where naturopathic medicine is not licensed. So whether you live in Barrie, Toronto or Thunder Bay, if you're okay with online visits, so are we!

Online video consults Ontario-wide Unlicensed provinces & territories
A nurse supporting a patient during a consultation

Let's get started

Become a patient.

Tell us a little about you and your diagnosis. Your intake goes straight to one of our nurses, who will reach out to walk you through next steps and book your first consultation.

1Complete the intake form. A few minutes — your details, your diagnosis, and the best way to reach you.
2Our team reviews and reaches out. We'll confirm fit, answer your questions, and schedule your consult.
3Schedule a consult. We build a supportive care plan that works alongside your oncology team.

Ready to begin?

The intake takes about 5–10 minutes, and a nurse reviews every submission personally before reaching out.

Start the intake form

References

  1. van der Louw EJTM, Olieman JF, van den Bemt PMLA, Bromberg JEC, Oomen-de Hoop E, Neuteboom RF, Catsman-Berrevoets CE, Vincent AJPE. Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study. Ther Adv Med Oncol. 2019 Jun 21;11:1758835919853958. doi: 10.1177/1758835919853958. PMID: 31258628; PMCID: PMC6589986.
  2. Wang J, Qi Q, Feng Z, Zhang X, Huang B, Chen A, Prestegarden L, Li X, Wang J. Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway. Oncotarget. 2016 Oct 11;7(41):66944-66958. doi: 10.18632/oncotarget.11396. PMID: 27557493; PMCID: PMC5341849.
  3. Qu H, Song X, Song Z, Jiang X, Gao X, Bai L, Wu J, Na L, Yao Z. Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma. Cancer Cell Int. 2020 Dec 9;20(1):592. doi: 10.1186/s12935-020-01693-y. PMID: 33298057; PMCID: PMC7727240.
  4. Couto RD, Fernandes BJD. Low Doses Naltrexone: The Potential Benefit Effects for its Use in Patients with Cancer. Curr Drug Res Rev. 2021;13(2):86-89. doi: 10.2174/2589977513666210127094222. PMID: 33504322.